PLEASANTON, Calif., Oct. 30, 2013 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced the appointment of Daniel G. McBride to executive vice president, chief operating officer and general counsel, effective November 1, 2013.
"I am very pleased to announce Dan's appointment to this new role," said Robert S. Weiss, Cooper's president and chief executive officer. "He has been instrumental in supporting our growth and development as a member of my executive team, and this new role will strengthen our focus on achieving our long-term operational goals."
Mr. McBride most recently served as vice president, general counsel and chief risk officer and has held positions of increasing responsibility within the legal organization focusing on operations, business development and long-term growth. Prior to joining Cooper in February 2005, Mr. McBride was an attorney with Latham & Watkins LLP concentrating on mergers and acquisitions and corporate finance.About The Cooper Companies The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 8,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com . Forward-Looking Statements This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements which are other than statements of historical fact, including our 2013 Guidance and all statements regarding anticipated growth in our revenue, expected results of operations and integration of any acquisition are forward-looking. To identify these statements look for words like "believes," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates" or "anticipates" and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties.